Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
22
NTLA Quote, Financials, Valuation and Earnings
Last price:
$9.59
Seasonality move
:
-4.79%
Day range:
$9.26 - $9.62
52-week range:
$5.90 - $28.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
17.47x
P/B ratio:
1.48x
Volume:
1.5M
Avg. volume:
4.4M
1-year change:
-20.41%
Market cap:
$1.1B
Revenue:
$57.9M
EPS (TTM):
-$4.27
Earnings Data
Next earnings date for NTLA
Feb 26
2026
Most recent earnings per share
-$0.92
Beat by $0.08
(Nov 6/2025)
Consensus Estimate
-$1.00
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NTLA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $12.2M | -- | -- | -$0.97 | -- |
| 11/06/2025 | Q3 | $14.1M | $13.8M | -$0.92 | -$1.00 | $0.08 |
| 08/07/2025 | Q2 | $12.2M | $14.2M | -$0.98 | -$1.01 | $0.03 |
| 05/08/2025 | Q1 | $12M | $16.6M | -$1.10 | -$1.27 | $0.17 |
| 02/27/2025 | Q4 | $8.1M | $12.9M | -$1.27 | -$1.32 | $0.05 |
| 11/07/2024 | Q3 | $7.2M | $9.1M | -$1.34 | -$1.37 | $0.03 |
| 08/08/2024 | Q2 | $18.5M | $7M | -$1.52 | -$1.20 | -$0.32 |
| 05/09/2024 | Q1 | $9.1M | $28.9M | -$1.13 | -$1.36 | $0.24 |
| 02/22/2024 | Q4 | $11.4M | -$1.9M | -$1.46 | -$1.44 | -$0.03 |
| 11/09/2023 | Q3 | $12M | $12M | -$1.38 | -$1.50 | $0.12 |
| 08/03/2023 | Q2 | -- | $13.6M | -$1.40 | -- | -- |
| 05/04/2023 | Q1 | -- | $12.6M | -$1.17 | -- | -- |
| 02/23/2023 | Q4 | -- | $13.6M | -$1.40 | -- | -- |
| 11/03/2022 | Q3 | -- | $13.3M | -$1.49 | -- | -- |
| 08/04/2022 | Q2 | -- | $14M | -$1.33 | -- | -- |
| 05/05/2022 | Q1 | -- | $11.3M | -$1.96 | -- | -- |
| 02/24/2022 | Q4 | -- | $12.9M | -$1.09 | -- | -- |
| 11/04/2021 | Q3 | -- | $7.2M | -$0.97 | -- | -- |
| 08/05/2021 | Q2 | -- | $6.6M | -$1.01 | -- | -- |
| 05/06/2021 | Q1 | -- | $6.4M | -$0.69 | -- | -- |
| 02/25/2021 | Q4 | -- | $6.6M | -$0.69 | -- | -- |
| 11/05/2020 | Q3 | -- | $22.2M | -$0.47 | -- | -- |
| 08/06/2020 | Q2 | -- | $16.3M | -$0.61 | -- | -- |
| 05/07/2020 | Q1 | -- | $12.9M | -$0.63 | -- | -- |
| 02/27/2020 | Q4 | -- | $10.9M | -$0.57 | -- | -- |
| 10/31/2019 | Q3 | -- | $10.6M | -$0.49 | -- | -- |
| 08/01/2019 | Q2 | -- | $11.1M | -$0.56 | -- | -- |
| 05/02/2019 | Q1 | -- | $10.4M | -$0.49 | -- | -- |
| 02/27/2019 | Q4 | -- | $7.9M | -$0.43 | -- | -- |
| 10/31/2018 | Q3 | -- | $7.4M | -$0.53 | -- | -- |
| 08/01/2018 | Q2 | -- | $7.7M | -$0.52 | -- | -- |
| 05/01/2018 | Q1 | -- | $7.5M | -$0.51 | -- | -- |
| 03/14/2018 | Q4 | -- | $6.7M | -$0.61 | -- | -- |
| 10/31/2017 | Q3 | -- | $7.3M | -$0.44 | -- | -- |
| 06/30/2017 | Q2 | -- | $5.9M | -$0.45 | -- | -- |
| 03/31/2017 | Q1 | -- | $6.2M | -$0.36 | -- | -- |
| 12/31/2016 | Q4 | -- | $5.6M | -$0.31 | -- | -- |
| 09/30/2016 | Q3 | -- | $4.9M | -$0.22 | -- | -- |
| 06/30/2016 | Q2 | -- | $4.2M | -$0.36 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.8M | -$9.89 | -- | -- |
Intellia Therapeutics, Inc. Earnings Questions
-
How Much did Intellia Therapeutics, Inc. Generate in Revenue Last Quarter?
Intellia Therapeutics, Inc. reported $13.8M worth of top line sales in its most recent quarter.
-
Did Intellia Therapeutics, Inc. Beat Earnings Last Quarter?
Intellia Therapeutics, Inc. announced earnings per share of -$0.92 which represents a beat of analyst forecast a -$1.00 per share.
-
Is Intellia Therapeutics, Inc. Profitable?
Intellia Therapeutics, Inc. reported $8.8M that represents $0.08 per share over the last quarter.
-
What is the Analyst Consensus for Intellia Therapeutics, Inc. EPS Next Year?
Intellia Therapeutics, Inc.'s earnings are forecast to decrease from -$5.25 per share to -$5.27 per share next year representing a decrease of -24.48%.
-
When is Intellia Therapeutics, Inc.'s Earnings Date?
Intellia Therapeutics, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
